ID   J26-G
AC   CVCL_XY24
DR   Wikidata; Q94325838
RX   PubMed=7479770;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; 914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; 4964; HLA-G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6487 ! J26
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
RX   PubMed=7479770; DOI=10.1073/pnas.92.22.10292; PMCID=PMC40782;
RA   Bensussan A., Mansur I.-G., Mallet V., Rodriguez A.-M., Aguerre-Girr M.,
RA   Weiss E.H., Brem G., Boumsell L., Gluckman E., Dausset J.,
RA   Carosella E.D., Le Bouteiller P.;
RT   "Detection of membrane-bound HLA-G translated products with a specific
RT   monoclonal antibody.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10292-10296(1995).
//